# Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related

> **NCT03313154** · — · COMPLETED · sponsor: **Azienda Ospedaliero Universitaria di Cagliari** · enrollment: 100 (actual)

## Conditions studied

- Psychiatric Disorders
- Cognitive Impairment
- Chronic Hepatitis c

## Interventions

- **OTHER:** Neuropsychiatric screening

## Key facts

- **NCT ID:** NCT03313154
- **Lead sponsor:** Azienda Ospedaliero Universitaria di Cagliari
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-07
- **Final completion:** 2018-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03313154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03313154, "Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03313154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*